Faes Farma, S.A. (BME:FAE)

Faes Farma Financials Overview

Financials in millions EUR. Fiscal year is January - December.

Revenue & Profits

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Revenue Revenue Growth	728.59	22	22.51	476.92	454.29	-10.59
Revenue Growth	33.69%	-2.23%	-95.28%	4.98%	-	-
Gross Profit Gross Profit Growth	608.07	-198.03	-150.72	319.04	304.98	-146.16
Operating Income Operating Income Growth	27.51	-522.08	-383.67	102.81	101.48	-335.39
Net Income Net Income Growth	84.18	79.63	111.36	91.9	89.5	82.39
Earnings Per Share EPS Growth	0.27	0.25	0.36	0.30	0.29	0.27
EPS Growth	-19.99%	-28.65%	20.27%	1.02%	8.52%	8.87%

Revenue by Segment

Chart

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Pharmaceutical Specialties and Healthcare Pharmaceutical Specialties and Healthcare Growth	544.47	455.21	416.88	400.78	366.85
Nutrition and Animal Health Nutrition and Animal Health Growth	79.32	52.2	52.66	59.3	60.38
Other Segments Other Segments Growth	3.2	2.64	3.55	1.64	1.42
Total Total Growth	626.99	510.04	473.09	461.72	428.64

Cash & Debt

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Investments Cash & Investments Growth	1.59	0	0	34.65	101.79	70.25
Total Debt Total Debt Growth	59.98	27.99	21.25	28.51	65.92	21.36
Net Cash (Debt) Net Cash Growth	-58.39	-27.99	-21.25	6.14	35.87	48.89
Net Cash Growth	-	-	-	-82.88%	-26.63%	-36.63%
Net Cash Per Share Net Cash Per Share Growth	-0.19	-0.09	-0.07	0.02	0.12	0.16

Cash Flow & CapEx

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Cash Flow Operating Cash Flow Growth	80.36	78.49	115.47	100.97	107.04	79.65
Capital Expenditures CapEx Growth	-17.83	-16.11	-33.81	-102.19	-80.95	-51.49
Free Cash Flow Free Cash Flow Growth	62.53	62.39	81.65	-1.22	26.09	28.16
Free Cash Flow Growth	-38.17%	-23.60%	-	-	-7.32%	-51.69%

Margins

Chart

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Gross Margin	83.46%	-900.04%	-669.70%	66.90%	67.13%	1379.65%
Operating Margin	3.78%	-2372.86%	-1704.83%	21.56%	22.34%	3165.81%
Pretax Margin	12.44%	388.21%	478.01%	21.57%	22.33%	-877.53%
Profit Margin	11.60%	362.08%	493.73%	19.23%	19.69%	-778.23%
FCF Margin	8.58%	283.54%	362.83%	-0.26%	5.74%	-265.76%

Dividends

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Dividend Per Share Dividend Per Share Growth	0.128	-	0.179	0.155	0.155	0.206
Dividend Per Share Growth	-28.49%	-	15.48%	0%	-24.76%	4.57%
Dividend Yield	2.84%	3.47%	4.45%	1.49%	1.75%	1.40%

Valuation

Chart

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 7, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
PE Ratio	16.91	20.32	9.78	10.68	11.57	12.44
Forward PE	14.01	18.27	11.65	11.04	12.10	12.89
P/FCF Ratio	22.59	25.75	13.27	-	39.77	34.95
PS Ratio	1.99	73.00	48.13	2.06	2.28	-92.89

Data Sources: Fiscal.ai and S&P Global Market Intelligence Last updated: Jul 23, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company. Revenue segment data is provided by S&P Global Market Intelligence.

Update frequency:

Quarterly

Last checked:

Aug 5, 2026

Data Sources Report a data error